Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
The disease is caused by a mutation in the gene encoding HMG CoA reductase, inhibiting the enzyme’s activity.
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
This artificial RNA ligase has higher thermostability than natural RNA ligase
According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year
OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
OriCiro's synthetic biology and enzyme technologies will support Moderna's expanding portfolio of therapeutics and vaccines
Subscribe To Our Newsletter & Stay Updated
